Lauren Gravitz is a freelance writer and editor in Hershey, Pennsylvania, who covers health, medicine, science and the environment. Her stories have appeared in Nature, Aeon, The Economist, Technology Review, O, The Oprah Magazine and Discover, among others.
Lauren Gravitz
Freelance Writer
From this contributor
A brief history of precision self-scanning
When a researcher solved a logistical problem by going rogue, the idea proved remarkably infectious.
A brief history of precision self-scanning
At the intersection of autism and trauma
Autism and post-traumatic stress disorder share many traits, but the connection between them was largely overlooked until now.
Autism’s drug problem
Many people on the spectrum take multiple medications — which can lead to serious side effects and may not even be effective.
Lack of DNA modification creates hotspots for mutations
The absence of a chemical alteration called methylation on some stretches of DNA makes them especially prone to mutations, according to a paper published in PLoS Genetics in May.
Lack of DNA modification creates hotspots for mutations
Explore more from The Transmitter
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.